361 related articles for article (PubMed ID: 26170166)
1. The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
Mishra M; Jiang H; Wu L; Chawsheen HA; Wei Q
Cancer Lett; 2015 Oct; 366(2):150-9. PubMed ID: 26170166
[TBL] [Abstract][Full Text] [Related]
2. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
Park JW; Mieyal JJ; Rhee SG; Chock PB
J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
[TBL] [Abstract][Full Text] [Related]
3. Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Wei Q; Jiang H; Xiao Z; Baker A; Young MR; Veenstra TD; Colburn NH
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7004-9. PubMed ID: 21487000
[TBL] [Abstract][Full Text] [Related]
4. Mapping the phenotypic repertoire of the cytoplasmic 2-Cys peroxiredoxin - Thioredoxin system. 1. Understanding commonalities and differences among cell types.
Selvaggio G; Coelho PMBM; Salvador A
Redox Biol; 2018 May; 15():297-315. PubMed ID: 29304480
[TBL] [Abstract][Full Text] [Related]
5. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG
Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188
[TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
7. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression.
Jeong W; Bae SH; Toledano MB; Rhee SG
Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055
[TBL] [Abstract][Full Text] [Related]
8. New insights on the differential interaction of sulfiredoxin with members of the peroxiredoxin family revealed by protein-protein docking and experimental studies.
Mishra M; Jiang H; Wei Q
Eur J Pharmacol; 2023 Sep; 954():175873. PubMed ID: 37353187
[TBL] [Abstract][Full Text] [Related]
9. Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators.
Chae HZ; Oubrahim H; Park JW; Rhee SG; Chock PB
Antioxid Redox Signal; 2012 Mar; 16(6):506-23. PubMed ID: 22114845
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
[TBL] [Abstract][Full Text] [Related]
12. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
Jönsson TJ; Murray MS; Johnson LC; Lowther WT
J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529
[TBL] [Abstract][Full Text] [Related]
13. The thioredoxin/peroxiredoxin/sulfiredoxin system: current overview on its redox function in plants and regulation by reactive oxygen and nitrogen species.
Sevilla F; Camejo D; Ortiz-Espín A; Calderón A; Lázaro JJ; Jiménez A
J Exp Bot; 2015 May; 66(10):2945-55. PubMed ID: 25873657
[TBL] [Abstract][Full Text] [Related]
14. Characterization of plant sulfiredoxin and role of sulphinic form of 2-Cys peroxiredoxin.
Iglesias-Baena I; Barranco-Medina S; Lázaro-Payo A; López-Jaramillo FJ; Sevilla F; Lázaro JJ
J Exp Bot; 2010 Mar; 61(5):1509-21. PubMed ID: 20176891
[TBL] [Abstract][Full Text] [Related]
15. Study of the signaling function of sulfiredoxin and peroxiredoxin III in isolated adrenal gland: unsuitability of clonal and primary adrenocortical cells.
Kil IS; Bae SH; Rhee SG
Methods Enzymol; 2013; 527():169-81. PubMed ID: 23830631
[TBL] [Abstract][Full Text] [Related]
16. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
17. The contribution of NADPH thioredoxin reductase C (NTRC) and sulfiredoxin to 2-Cys peroxiredoxin overoxidation in Arabidopsis thaliana chloroplasts.
Puerto-Galán L; Pérez-Ruiz JM; Guinea M; Cejudo FJ
J Exp Bot; 2015 May; 66(10):2957-66. PubMed ID: 25560178
[TBL] [Abstract][Full Text] [Related]
18. Sulfiredoxin: a potential therapeutic agent?
Findlay VJ; Tapiero H; Townsend DM
Biomed Pharmacother; 2005 Aug; 59(7):374-9. PubMed ID: 16102934
[TBL] [Abstract][Full Text] [Related]
19. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.
Lowther WT; Haynes AC
Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
